BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15159057)

  • 1. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.
    Hawlisch H; Wills-Karp M; Karp CL; Köhl J
    Mol Immunol; 2004 Jun; 41(2-3):123-31. PubMed ID: 15159057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
    Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
    Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma.
    Schmudde I; Laumonnier Y; Köhl J
    Semin Immunol; 2013 Feb; 25(1):2-11. PubMed ID: 23694705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
    Sunyer JO; Boshra H; Li J
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of anaphylatoxins and their receptors in allergic asthma.
    Laumonnier Y; Wiese AV; Figge J; Karsten C
    Mol Immunol; 2017 Apr; 84():51-56. PubMed ID: 27916272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex role for complement in allergic asthma.
    Zhang X; Köhl J
    Expert Rev Clin Immunol; 2010 Mar; 6(2):269-77. PubMed ID: 20402389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization.
    Lambrecht BN
    J Clin Invest; 2006 Mar; 116(3):628-32. PubMed ID: 16511597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new face of anaphylatoxins in immune regulation.
    Zhou W
    Immunobiology; 2012 Feb; 217(2):225-34. PubMed ID: 21856033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylatoxins and infectious and non-infectious inflammatory diseases.
    Köhl J
    Mol Immunol; 2001 Aug; 38(2-3):175-87. PubMed ID: 11532279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual role for complement in allergic asthma.
    Köhl J; Wills-Karp M
    Curr Opin Pharmacol; 2007 Jun; 7(3):283-9. PubMed ID: 17475559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self, non-self, and danger: a complementary view.
    Köhl J
    Adv Exp Med Biol; 2006; 586():71-94. PubMed ID: 16893066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin C3a receptors in asthma.
    Ali H; Panettieri RA
    Respir Res; 2005 Feb; 6(1):19. PubMed ID: 15723703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
    Peng Q; Li K; Sacks SH; Zhou W
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
    Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
    Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement in lung disease.
    Sarma VJ; Huber-Lang M; Ward PA
    Autoimmunity; 2006 Aug; 39(5):387-94. PubMed ID: 16923538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical applications of recombinant complement inhibitors].
    Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R
    Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.